239 related articles for article (PubMed ID: 16778113)
1. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
Schönleben F; Qiu W; Ciau NT; Ho DJ; Li X; Allendorf JD; Remotti HE; Su GH
Clin Cancer Res; 2006 Jun; 12(12):3851-5. PubMed ID: 16778113
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.
Schönleben F; Qiu W; Remotti HE; Hohenberger W; Su GH
Langenbecks Arch Surg; 2008 May; 393(3):289-96. PubMed ID: 18343945
[TBL] [Abstract][Full Text] [Related]
3. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.
Schönleben F; Qiu W; Bruckman KC; Ciau NT; Li X; Lauerman MH; Frucht H; Chabot JA; Allendorf JD; Remotti HE; Su GH
Cancer Lett; 2007 May; 249(2):242-8. PubMed ID: 17097223
[TBL] [Abstract][Full Text] [Related]
4. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
5. PIK3CA mutations in head and neck squamous cell carcinoma.
Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
[TBL] [Abstract][Full Text] [Related]
6. Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.
Garcia-Carracedo D; Turk AT; Fine SA; Akhavan N; Tweel BC; Parsons R; Chabot JA; Allendorf JD; Genkinger JM; Remotti HE; Su GH
Clin Cancer Res; 2013 Dec; 19(24):6830-41. PubMed ID: 24132918
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutations in mucinous cystic neoplasms of the pancreas.
Garcia-Carracedo D; Chen ZM; Qiu W; Huang AS; Tang SM; Hruban RH; Su GH
Pancreas; 2014 Mar; 43(2):245-9. PubMed ID: 24518503
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shiratori K; Kawamura S; Kobayashi M; Shimizu M; Ban S; Koyama I; Higashi M; Shin N; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Harada Y; Furukawa T
Am J Surg Pathol; 2011 Dec; 35(12):1812-7. PubMed ID: 21945955
[TBL] [Abstract][Full Text] [Related]
10. Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.
Schönleben F; Allendorf JD; Qiu W; Li X; Ho DJ; Ciau NT; Fine RL; Chabot JA; Remotti HE; Su GH
Pancreas; 2008 Mar; 36(2):168-72. PubMed ID: 18376308
[TBL] [Abstract][Full Text] [Related]
11. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
15. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
16. Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression.
Durante S; Vecchiarelli S; Astolfi A; Grassi E; Casadei R; Santini D; Panzacchi R; Ricci C; Serravalle S; Tarantino G; Falconi M; Teti G; Indio V; Pession A; Minni F; Biasco G; Di Marco M
Oncotarget; 2016 Nov; 7(46):74797-74806. PubMed ID: 27566563
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
[TBL] [Abstract][Full Text] [Related]
19. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
Barbareschi M; Buttitta F; Felicioni L; Cotrupi S; Barassi F; Del Grammastro M; Ferro A; Dalla Palma P; Galligioni E; Marchetti A
Clin Cancer Res; 2007 Oct; 13(20):6064-9. PubMed ID: 17947469
[TBL] [Abstract][Full Text] [Related]
20. Intraductal carcinosarcoma with a heterologous mesenchymal component originating in intraductal papillary-mucinous carcinoma (IPMC) of the pancreas with both carcinoma and osteosarcoma cells arising from IPMC cells.
Okamura J; Sekine S; Nara S; Ojima H; Shimada K; Kanai Y; Hiraoka N
J Clin Pathol; 2010 Mar; 63(3):266-9. PubMed ID: 20203229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]